KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Income towards Parent Company (2016 - 2025)

Teladoc Health's Income towards Parent Company history spans 12 years, with the latest figure at -$25.1 million for Q4 2025.

  • For Q4 2025, Income towards Parent Company rose 48.08% year-over-year to -$25.1 million; the TTM value through Dec 2025 reached -$200.3 million, up 79.99%, while the annual FY2025 figure was -$200.3 million, 79.99% up from the prior year.
  • Income towards Parent Company for Q4 2025 was -$25.1 million at Teladoc Health, up from -$49.6 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$11.0 million in Q4 2021 and bottomed at -$6.7 billion in Q1 2022.
  • The 5-year median for Income towards Parent Company is -$71.4 million (2022), against an average of -$775.5 million.
  • The largest annual shift saw Income towards Parent Company plummeted 34584.31% in 2022 before it surged 99.24% in 2023.
  • A 5-year view of Income towards Parent Company shows it stood at -$11.0 million in 2021, then tumbled by 34584.31% to -$3.8 billion in 2022, then soared by 99.24% to -$28.9 million in 2023, then tumbled by 67.4% to -$48.4 million in 2024, then surged by 48.08% to -$25.1 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Income towards Parent Company are -$25.1 million (Q4 2025), -$49.6 million (Q3 2025), and -$32.6 million (Q2 2025).